Oscar Health names Sankaran as board chair effective June 2026

Oscar Health, Inc. (NYSE: OSCR) announced the appointment of independent director Siddhartha Sankaran as Chair of the Board, effective June 4, 2026. Sankaran will succeed Jeffery Boyd, who has served as Chair since February 2021 and is not standing for reelection at the company's annual meeting.

Sankaran brings more than 20 years of leadership experience in the insurance industry, having served in executive roles at American International Group, Inc., SiriusPoint Ltd. and FWD Group Holdings Limited. He has served on Oscar Health's Board for five years.

"I am thrilled to have Sid lead our Board through Oscar's next phase," said Mark Bertolini, Oscar Health's Chief Executive Officer. "I also want to thank Jeff for his tireless commitment, first as a trusted advisor and through our IPO and beyond."

Boyd commented on his tenure: "It's been a privilege to be a part of Oscar's transformation from bold startup into a leader in the individual market. The past 12 years have been an incredible run."

Sankaran stated: "I am honored to step into this role at a pivotal moment for Oscar and for healthcare. The Oscar team is redefining the healthcare experience and building a more efficient market that works for everyone."

The transition represents a leadership change for the healthcare technology company, which operates Individual & Family plans and ICHRA solutions, along with technology services and marketplace offerings. The information is based on a company press release statement.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Texas Capital Securities Downgrades Arcosa (ACA) to Hold
• Bending Spoons valuation up to $19 Billion in U.S. IPO - Reuters